+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Neuromodulation: Deep Brain Stimulation and Vagus Nerve Stimulation Devices Market

  • ID: 5086951
  • Report
  • May 2020
  • Region: Global
  • 111 pages
  • MedDeviceTracker
1 of 3

FEATURED COMPANIES

  • Abbott
  • Boston Scientific
  • LivaNova
  • Medtronic
  • NeuroPace
  • MORE
Overview

Global sales of neuromodulation systems for the treatment of movement disorders (Parkinson’s disease, essential tremor, and dystonia) and epilepsy, which include implantable deep brain stimulation (DBS) and vagus nerve stimulation (VNS) devices, respectively, are expected to increase at a CAGR of approximately 8.5%, from nearly $1.2bn in 2019 to approximately $1.8bn in 2024.

The highly competitive DBS and VNS segments - which contribute nearly one-third of the global $4.5bn+ neuromodulation market - are significantly underpenetrated, with substantial room for growth. The DBS/VNS markets are being driven by several positive factors, including: a long clinical history with a substantial reduction in debilitating symptoms, strong marketing and surgeon training efforts, and technological innovation (eg new directional lead technologies, precisely targeted stimulation, and therapy customization). The launch of next-generation DBS and VNS systems are further improving outcomes and providing patients with incurable neurological conditions a safe, effective, and long-term device-based therapy alternative.

The report provides the following useful information:
  • An overview of neuromodulation technology for the treatment of refractory neurological movement disorders and epilepsy
  • Key epidemiology data on the prevalence of Parkinson’s disease, essential tremor, dystonia, epilepsy, and depression
  • Related product portfolios offered by leading manufacturers
  • Top selling neuromodulation devices, as well as emerging products under development
  • In-depth market and competitive analyses.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott
  • Boston Scientific
  • LivaNova
  • Medtronic
  • NeuroPace
  • MORE
Executive Summary
  • Combined market
  • Selected market drivers and limiters
  • Deep brain stimulation devices segment
  • Vagus nerve stimulation devices segment
  • Market leaders
  • Methodology
1. Clinical Overview
1.1 Deep brain stimulation
1.2 Vagus nerve stimulation
1.3 Movement disorders
1.3.1 Parkinson’s disease
1.3.2 Essential tremor
1.3.3 Dystonia
1.4 Epilepsy
1.5 Major depressive disorder
1.6 Prevalence of neurological disorders
1.7 Bibliography

2. Deep Brain Stimulation Technology
2.1 Selected products
2.1.1 Abbott
2.1.2 Boston Scientific
2.1.3 Medtronic
2.2 Bibliography

3. Vagus Nerve Stimulation Technology
3.1 Selected products
3.1.1 LivaNova
3.1.2 Medtronic
3.1.3 NeuroPace
3.2 Bibliography

4. Market Analysis
4.1 Deep brain stimulation devices market
4.1.1 Market forecast: global
4.1.2 Market forecast: by region
4.1.3 Market drivers and limiters
4.1.4 Market share: global
4.1.5 Market share: by region
4.2 Vagus nerve stimulation devices market
4.2.1 Market forecast: global
4.2.2 Market forecast: by region
4.2.3 Market drivers and limiters
4.2.4 Market share: global
4.2.5 Market share: by region
4.3 Combined market
4.4 Corporate profiles
4.4.1 Abbott
4.4.2 Boston Scientific
4.4.3 LivaNova
4.4.4 Medtronic
4.5 Bibliography

List of Exhibits

Exhibit ES-1: Deep brain stimulation and vagus nerve stimulation devices, combined market forecast ($m), by segment, 2019–24
Exhibit ES-2: Deep brain stimulation devices market, forecast sales by region ($m), 2019–24
Exhibit ES-3: Vagus nerve stimulation devices, forecast sales by region ($m), 2019–24
Exhibit 1-1: Diagram of Medtronic’s deep brain stimulation system implantation
Exhibit 1-2: Diagram of vagus nerve stimulation therapy
Exhibit 1-3: Prevalence of movement disorders, epilepsy and depression
Exhibit 2-1: Implantable deep brain stimulation systems for movement disorders
Exhibit 2-2: Abbott’s Infinity DBS system with proprietary directional leads
Exhibit 2-3: Boston Scientific’s Vercise DBS portfolio, including new Vercise Gevia with Cartesia Directional Lead
Exhibit 2-4: Medtronic’s Activa DBS systems
Exhibit 2-5: Medtronic’s new Percept PC DBS system with BrainSense Technology
Exhibit 2-6: Medtronic DBS therapy indications
Exhibit 3-1: Vagus nerve stimulation using implantable VNS Therapy
Exhibit 3-2: Neuromodulation systems for the treatment of epilepsy
Exhibit 3-3: LivaNova’s SenTiva VNS Therapy System
Exhibit 3-4: The anterior nucleus of the thalamus
Exhibit 3-5: The NeuroPace RNS System
Exhibit 4-1: Deep brain stimulation devices, global market forecast ($m), 2019–24
Exhibit 4-2: Deep brain stimulation devices market, estimated sales and share of revenues by region, 2019
Exhibit 4-3: Deep brain stimulation devices market, forecast sales by region ($m), 2019–24
Exhibit 4-4: Deep brain stimulation devices market, estimated global share by supplier, 2019
Exhibit 4-5: Selected noninvasive brain stimulation systems
Exhibit 4-6: Deep brain stimulation devices market ($m), estimated share by supplier and region, 2019
Exhibit 4-7: Vagus nerve stimulation devices, global market forecast ($m), 2019–24
Exhibit 4-8: Vagus nerve neurostimulation devices, estimated share of revenues by region, 2019
Exhibit 4-9: Vagus nerve stimulation devices, forecast sales by region ($m), 2019–24
Exhibit 4-10: Vagus nerve stimulation devices market, estimated global share by supplier, 2019
Exhibit 4-11: Vagus nerve stimulation devices market, estimated share by supplier and region, 2019
Exhibit 4-12: Combined deep brain stimulation and vagus nerve stimulation devices market, forecast sales by segment ($m), 2019–24
Exhibit 4-13: Abbott, revenues by segment, FY2019
Exhibit 4-14: Boston Scientific, revenues by segment, FY2019
Exhibit 4-15: LivaNova, revenues by segment, FY2019
Exhibit 4-16: Medtronic, revenues by segment, FY2019

Appendix A: Company listing
Note: Product cover images may vary from those shown
3 of 3
  • Abbott
  • Boston Scientific
  • LivaNova
  • Medtronic
  • NeuroPace
Note: Product cover images may vary from those shown
Adroll
adroll